RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis
1 other identifier
observational
10
1 country
1
Brief Summary
Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2025
CompletedFirst Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 2, 2025
September 1, 2025
12 months
November 20, 2025
November 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
RNA profile
The diseased mucosa will show a increased fibrosis and inflammation profile compared with that from normal mucosa
1 year
Study Arms (1)
patients with benign tracheal stenosis undergoing either endoscopic or surgical treatment
Interventions
The tissue will be obtained from biopsy or surgical resection. All the "intervention" will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue
Eligibility Criteria
patients with benign tracheal stenosis, including idiopathic, iatrogenic, autoimmune.
You may qualify if:
- Patients with benign tracheal stenosis
You may not qualify if:
- Malignancy. active infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maryland
Baltimore, Maryland, 21201, United States
Biospecimen
Biopsied or resected stenotic tissue from patients with benign tracheal stenosis
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 2, 2025
Study Start
September 11, 2025
Primary Completion (Estimated)
September 10, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 2, 2025
Record last verified: 2025-09